Latest News & Features
Europe
As the drug moves deeper into its post-exclusivity phase, a Nordic decision highlights the value of secondary patents, presumption of validity, and interim relief when a drug's core patents expire. 13 January 2026
Careers
An experienced Ex-Hoffmann Eitle litigator, who worked on Sanofi v Amgen, joins the firm's growing UPC team in Munich, Germany. 12 January 2026
Americas
After “seismic” changes imposed by the USPTO last year, litigating patents will become significantly more difficult and costly to defend, and both plaintiffs and defendants must urgently retool their strategies, advise lawyers from BCLP. 12 January 2026
Americas
A busy week in US courts saw major pharma companies and biotech firms move to protect key therapies and research tools, with new lawsuits over migraine and cancer drug generics, and alleged misuse of COVID-19 vaccine tech. 9 January 2026
Europe
Traceability and transparency of training practices, and the value of bespoke tool, are among the key AI trends that will be shaped by legal and regulatory developments in 2026, write experts from Rouse. 9 January 2026
Europe
A first-of-its-kind project by sister title WIPR aims to highlight the world’s leading in-house intellectual property counsel—and it needs your help. 9 January 2026
Careers
Simon Wright says he will focus on engagement with in-house and SME members, as well as support the UK rejoining the UPC and more as he takes the reins at the Chartered Institute of Patent Attorneys. 9 January 2026
Americas
Important questions about when companies must act on suspicions of theft and whether damages can stack with injunctions were raised in a dispute that has already sent ripples across med tech. 8 January 2026
Americas
Crop science division alleges that vaccine developers used patented mRNA stability technology in shots that earned them around $140 billion in global sales. 8 January 2026
Careers
A Brussels-based partner, specialising in pharmaceuticals and biologics, jumps ship as a competitor firm continues to build out its EU healthcare regulatory bench. 7 January 2026